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introduction
Much progress has been achieved since the publication of “A
Compendium of Strategies to Prevent Healthcare-Associated
Infections in Acute Care Hospitals”1-7 in October 2008. In
2009, the US Department of Health and Human Services
(HHS) released a national healthcare-associated infection
(HAI) action plan8 focused on preventing central line–
associated bloodstream infections (CLABSI), catheter-asso-
ciated urinary tract infections (CAUTI), surgical site infec-
tions (SSI), methicillin-resistant Staphylococcus aureus
(MRSA) bloodstream infections, and Clostridium difficile in-
fections (CDI) in acute care hospitals. In 2011, the Centers
for Medicare and Medicaid Services (CMS) began requiring
acute care hospitals to report specific types of HAI data to
CMS through the Centers for Disease Control and Preven-
tion’s (CDC’s) National Healthcare Safety Network (NHSN)
in order to receive their full annual reimbursement updates,
vastly expanding the breadth of hospitals contributing sur-
veillance information into the NHSN national repository of
HAI data.9 Also in 2011, HHS launched a public-private ini-
tiative called the Partnership for Patients: Better Care, Lower
Costs, aimed at improving the quality, safety, and affordability
of US healthcare.10 Based on HAI surveillance data collected
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table 1. Grading of the Quality of Evidence
Grade Definition
I. High Highly confident that the true effect lies close to that of the estimated size and direction of the
effect. Evidence is rated as high quality when there is a wide range of studies with no major
limitations, there is little variation between studies, and the summary estimate has a narrow
confidence interval.
II. Moderate The true effect is likely to be close to the estimated size and direction of the effect, but there is
a possibility that it is substantially different. Evidence is rated as moderate quality when there
are only a few studies and some have limitations but not major flaws, there is some variation
between studies, or the confidence interval of the summary estimate is wide.
III. Low The true effect may be substantially different from the estimated size and direction of the effect.
Evidence is rated as low quality when supporting studies have major flaws, there is important
variation between studies, the confidence interval of the summary estimate is very wide, or
there are no rigorous studies, only expert consensus.
note. Based on Grades of Recommendation, Assessment, Development, and Evaluation (GRADE)13 and the
Canadian Task Force on Preventive Health Care.14
by NHSN, substantial improvements have been achieved in
preventing CLABSI and SSI within the last several years.11
Continued progress in healthcare epidemiology and im-
plementation science research has led to improvements in
our understanding of effective strategies for HAI prevention.
Despite these advancements, HAIs continue to affect about
1 out of every 20 hospitalized patients, leading to substantial
morbidity, mortality, and excess healthcare expenditures,12
and there are persistent gaps between what is recommended
and what is practiced.
the compendium of strategies to
prevent healthcare-associated
infections in acute care hospitals
The major aim of the original documents published in 2008
and the 2014 updates is to provide acute care hospitals with
up-to-date, practical, relatively concise expert guidance to
assist in prioritizing and implementing HAI prevention ef-
forts. These articles are the products of a highly collaborative
effort led by the Society for Healthcare Epidemiology of
America (SHEA), the Infectious Diseases Society of America
(IDSA), the American Hospital Association (AHA), the As-
sociation for Professionals in Infection Control and Epide-
miology (APIC), and The Joint Commission, with major con-
tributions from representatives of a number of organizations
and societies with content expertise, including the CDC, the
Institute for Healthcare Improvement (IHI), the Pediatric
Infectious Diseases Society (PIDS), the Society for Critical
Care Medicine (SCCM), the Society for Hospital Medicine
(SHM), and the Surgical Infection Society (SIS).
Consistent with the 2008 version of the Compendium, the
recommendations within the updated documents are largely
based on previously published HAI prevention guidelines
available from a number of organizations, including the
Healthcare Infection Control Practices Advisory Committee
(HICPAC), the CDC, SHEA, IDSA, and APIC, as well as other
relevant published literature and the consensus of the content
experts who served as section panel members. The Compen-
dium does not reflect a complete systematic review of the
medical literature and is not meant to supplant previously
published guidelines and systematic reviews, but instead aims
to provide acute care hospitals with a summary of practical,
relatively concise guidance based largely on these documents.
An expert review panel evaluated each article in detail to
assess the material included and to ensure that the level of
evidence assigned to each recommendation was appropriate.
major changes to the compendium
In addition to updated recommendations in each of the ar-
ticles, major changes in the 2014 updates to the Compendium
include a new guidance document that reviews evidence-
based strategies to improve hand hygiene and metrics to assess
performance. In addition, a new segment has been added to
each of the Compendium articles that briefly describes ex-
amples of published implementation strategies and provides
references that hospitals can access for more detailed
information.
Seven Compendium articles are now included, with six
focused on specific types of HAIs and one new section focused
on hand hygiene improvement strategies. Each section con-
tains a statement of concern, a brief summary of previously
described detection and prevention approaches, recom-
mended infection prevention strategies, proposed perfor-
mance measures, and examples of implementation strategies
for consideration.
Each infection prevention recommendation was assigned
a grading of evidence rating (low, moderate, or high level of
evidence) adapted from criteria utilized by the Grades of
Recommendation, Assessment, Development, and Evaluation
(GRADE) system13 and the Canadian Task Force on Preven-
tive Health Care14 (Table 1).
Recommendations are categorized as either (1) basic prac-
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tices that should be adopted by all acute care hospitals or (2)
special approaches that can be considered for use in locations
and/or populations within hospitals when HAIs are not con-
trolled after full implementation of basic practices. The de-
cisions to categorize a recommendation as a basic practice
versus a special approach were made through consensus of
the section writing panel with input from expert panel mem-
bers based on the quality of evidence and the balance between
desirable and potentially undesirable effects of various inter-
ventions. Basic practices include recommendations where the
potential to impact HAI risk clearly outweighs the potential
for undesirable effects.
Special approaches include recommendations where the
intervention is likely to reduce HAI risk but where there is
concern about the risks for undesirable outcomes, where the
quality of evidence is low, or where evidence supports the
impact of the intervention in select settings (eg, during out-
breaks) or for select patient populations. Hospitals can pri-
oritize their efforts by initially focusing on implementation
of the prevention approaches listed as basic practices. If HAI
surveillance or other risk assessment suggests that there are
ongoing opportunities for improvement, hospitals should
then consider adopting some or all of the prevention strategies
listed as special approaches. These can be implemented in
specific locations or patient populations or can be imple-
mented hospital-wide, depending on outcome data, risk as-
sessment, and/or local requirements.
methods
SHEA and the IDSA Standards and Practice Guidelines Com-
mittee recruited two experts in the prevention of HAIs to be
section panel leads for each Compendium article. Additional
section panel members representing SHEA, IDSA, CDC, The
Joint Commission, APIC, PIDS, and SCCM were selected as
appropriate to their areas of expertise. Expert panel members
with broad healthcare epidemiology and infection prevention
expertise were convened to review draft manuscripts and to
provide input to each section panel. An advisory group con-
sisting of representatives from the five major partnering or-
ganizations (SHEA, IDSA, APIC, The Joint Commission, and
AHA) provided broad oversight over the Compendium writ-
ing process (see Compendium Leadership section at end of
the text). All participants complied with the SHEA and IDSA
policies on conflict of interest disclosure.
Literature Review and Analysis
Section panel members reviewed previously published guide-
lines, systematic reviews, and meta-analyses as well as relevant
literature published since 2008.
Consensus Development
Section panel members for each Compendium article met as
needed via teleconference to discuss recommendations, rank-
ing of the quality of evidence for these recommendations,
and classification as basic practices, special approaches, or
unresolved issues. Section leads assigned responsibilities to
panel members. Compendium article drafts were reviewed
and final versions were approved by the respective section
panel members.
Review and Approval Process
A critical stage in the development process is peer review.
Peer reviewers are relied on for expert, critical, and unbiased
scientific appraisals of the documents. SHEA and IDSA em-
ployed a process that included multilevel review and approval.
Comments were obtained from the expert panel members
who complied with the SHEA and IDSA policies on conflict
of interest disclosure. In addition, the 5 partnering organi-
zations as well as a number of stakeholder organizations pro-
vided comments, support, and endorsement (see Endorsing
and Supporting Organizations section at end of text). Finally,
the guidance documents were reviewed and approved by the
SHEA Guidelines Committee, the IDSA Standards and Prac-
tice Guidelines Committee, and the board of directors of
SHEA, IDSA, APIC, and The Joint Commission before
dissemination.
Disclosure of Conflicts of Interest
All members of the Compendium section panels, expert
panel, and advisory group complied with the IDSA and SHEA
policies on conflicts of interest, which require disclosure of
any financial or other interest within the past 2 years that
might be construed as constituting an actual, potential, or
apparent conflict. All participants were provided with the
SHEA conflicts of interest disclosure statement and were
asked to identify ties to companies developing products that
might be affected by promulgation of the Compendium. In-
formation was requested regarding employment, consultan-
cies, stock ownership, honoraria, research funding, expert
testimony, and membership on company advisory commit-
tees, and participants with potential conflicts were required
to submit a plan detailing the process that would be used to
avoid conflicts. Decisions were made by the Compendium
co-chairs and a disclosure review committee on a case-by-
case basis as to whether an individual’s role should be limited
as a result of a conflict. Potential conflicts are listed in the
Acknowledgments of each section.
Mechanism for Updating the Compendium
At annual intervals, the SHEA Guidelines Committee, in col-
laboration with IDSA, AHA, APIC, and The Joint Commis-
sion, will determine the need for revisions to the Compen-
dium on the basis of an examination of the current literature.
If necessary, the section leads and other content experts will
be consulted to discuss the need for changes.
This content downloaded from 130.92.9.56 on Wed, 23 Apr 2014 05:48:28 AM
All use subject to JSTOR Terms and Conditions
458 infection control and hospital epidemiology may 2014, vol. 35, no. 5
compendium leadership
Society for Healthcare Epidemiology of America (SHEA)
Co-Lead
Deborah S. Yokoe, MD, MPH
Infectious Diseases Society of America (IDSA) Co-Lead
Lisa L. Maragakis, MD, MPH
Compendium Advisory Group
Eve Humphreys, MBA, CAE (SHEA)
Valerie Deloney, MBA (SHEA)
Kristina Bryant, MD (SHEA Guidelines Committee chair)
Jennifer Padberg, MPH (IDSA)
Nancy Foster (AHA)
Katrina Crist, MBA (APIC)
Tom Weaver, DMD (APIC)
Kelly Podgorny, RN, MS, CPHQ (The Joint Commission)
Margaret VanAmringe, MHS (The Joint Commission)
Robert Wise, MD (The Joint Commission)
David Classen, MD, MS (2008 Compendium Co-Lead)
Compendium Expert Panel
Neil Fishman, MD
Donald Goldmann, MD
John Jernigan, MD, MS
Trish M. Perl, MD, MSc
Edward Septimus, MD
Robert Weinstein, MD
Compendium Section Leads
Evelyn Lo, MD (catheter-associated urinary tract infec-
tions [CAUTI])
Lindsay Nicolle, MD (CAUTI)
Erik R. Dubberke, MD, MSPH (Clostridium difficile infec-
tion [CDI])
Dale N. Gerding, MD (CDI)
Jonas Marschall, MD (central line–associated bloodstream
infections [CLABSI])
Leonard A. Mermel, DO, ScM (CLABSI)
Kate Ellingson, PhD (hand hygiene)
Janet Haas, PhD, RN (hand hygiene)
David P. Calfee, MD, MS (methicillin-resistant Staphylo-
coccus aureus [MRSA])
Cassandra Salgado, MD, MS (MRSA)
Deverick J. Anderson, MD, MPH (surgical site infections
[SSI])
Keith S. Kaye, MD, MPH (SSI)
Michael Klompas, MD, MPH (ventilator-associated pneu-
monia [VAP])
Sean M. Berenholtz, MD, MHS (VAP)
compendium partners
Society for Healthcare Epidemiology (SHEA)
Infectious Diseases Society of America (IDSA)
American Hospital Association (AHA)
Association for Professionals in Infection Control and
Epidemiology (APIC)
The Joint Commission
endorsing and supporting
organizations
Endorsing organizations reviewed and approved the 2014
updates to the Compendium. Supporting organizations
provided general nonfinancial support for these updates.
Organizations whose endorsement and support were
pending at the time of publication will be added at a
later date.
Endorsing Organizations
American Association of Critical-Care Nurses (AACN)
American Organization of Nurse Executives (AONE)
Council of State and Territorial Epidemiologists (CSTE)
European Society of Clinical Microbiology and Infectious
Diseases (ESCMID; provided endorsement specifically
for the “Strategies to Prevent Catheter-Associated Uri-
nary Tract Infections in Acute Care Hospitals: 2014 Up-
date” and the “Strategies to Prevent Healthcare-Asso-
ciated Infections through Hand Hygiene: 2014 Update”
portions of the Compendium)
HCA Health System
Infusion Nurses Society (INS; provided endorsement spe-
cifically for the “Strategies to Prevent Central Line–
Associated Bloodstream Infections in Acute Care Hos-
pitals: 2014 Update” and the “Strategies to Prevent
Healthcare-Associated Infections through Hand Hy-
giene: 2014 Update” portions of the Compendium)
Institute for Healthcare Improvement (IHI)
National Foundation for Infectious Diseases (NFID)
Pediatric Infectious Diseases Society (PIDS)
Society for Critical Care Medicine (SCCM)
Society for Hospital Medicine (SHM)
Surgical Infection Society (SIS)
Supporting Organizations
American Society of Healthcare Risk Management
(ASHRM)
Infusion Nurses Society (INS; provided support specifically
for the “Strategies to Prevent Surgical Site Infections in
Acute Care Hospitals: 2014 Update,” the “Strategies to
Prevent Clostridium difficile Infections in Acute Care
Hospitals: 2014 Update,” the “Strategies to Prevent Cath-
eter-Associated Urinary Tract Infections in Acute Care
Hospitals: 2014 Update,” the “Strategies to Prevent
Methicillin-Resistant Staphylococcus aureus Infections in
This content downloaded from 130.92.9.56 on Wed, 23 Apr 2014 05:48:28 AM
All use subject to JSTOR Terms and Conditions
introduction to compendium: 2014 updates 459
Acute Care Hospitals: 2014 Update,” and the “Strategies
to Prevent Ventilator-Associated Infections in Acute
Care Hospitals: 2014 Update” portions of the
Compendium)
Johns Hopkins Medicine
Partners HealthCare
Society of Infectious Diseases Pharmacists (SIDP)
Trust for America’s Health (TFAH)
acknowledgments
We thank Valerie Deloney, whose organizational expertise and tireless assis-
tance has made this work possible.
Disclaimer. K.D.E.—The findings and conclusions in this report are those
of the author and do not necessarily represent the official position of the
Centers for Disease Control and Prevention.
Financial support. Support for this Compendium was provided by the
Society for Healthcare Epidemiology of America.
Potential conflicts of interest. All authors report no conflicts of interest
relevant to this article.
Address correspondence to Deborah S. Yokoe, MD, MPH, 181 Longwood
Avenue, Boston, MA 02115 (dyokoe@partners.org).
references
1. Yokoe DS, Mermel LA, Anderson DJ, et al. Executive summary:
a Compendium of strategies to prevent healthcare-associated
infections in acute care hospitals. Infect Control Hosp Epidemiol
2008;29(suppl 1):S12–S21.
2. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent
central line–associated bloodstream infections in acute care hos-
pitals. Infect Control Hosp Epidemiol 2008;29(suppl 1):S22–S30.
3. Coffin SE, Klompas M, Classen D, et al. Strategies to prevent
ventilator-associated pneumonia in acute care hospitals. Infect
Control Hosp Epidemiol 2008;29(suppl 1):S31–S40.
4. Lo E, Nicolle L, Classen D, et al. Strategies to prevent catheter-
associated urinary tract infections in acute care hospitals. Infect
Control Hosp Epidemiol 2008;29(suppl 1):S41–S50.
5. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent
surgical site infections in acute care hospitals. Infect Control Hosp
Epidemiol 2008;29(suppl 1):S51–S61.
6. Calfee DP, Salgado CD, Classen D, et al. Strategies to prevent
transmission of methicillin-resistant Staphylococcus aureus in
acute care hospitals. Infect Control Hosp Epidemiol 2008;29(suppl
1):S62–S80.
7. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent
Clostridium difficile infections in acute care hospitals. Infect Con-
trol Hosp Epidemiol 2008;29(suppl 1):S81–S92.
8. US Department of Health and Human Services. National action
plan to prevent health care–associated infections: road map to
elimination. http://www.hhs.gov/ash/initiatives/hai/actionplan/.
Accessed December 31, 2013.
9. Centers for Medicare and Medicaid Services. Acute inpatient
PPS. https://www.cms.gov/Medicare/Medicare-Fee-for-Service
-Payment/AcuteInpatientPPS/index.html?redirectp
/AcuteInpatientPPS/FR2012/list.asp. Accessed December 31,
2013.
10. Centers for Medicare and Medicaid Services. Partnership for
patients. http://partnershipforpatients.cms.gov/. Accessed De-
cember 31, 2013.
11. Malpiedi PJ, Peterson KD, Soe MM, et al. 2011 national and
state healthcare-associated infection standardized infection ratio
report. Published February 11, 2013. http://www.cdc.gov/hai
/national-annual-sir/index.html. Accessed December 31, 2013.
12. Klevens RM, Edwards JR, Richards CL, et al. Estimating health
care–associated infections and deaths in US hospitals: 2002. Pub-
lic Health Rep 2007;122:160–166.
13. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging
consensus on rating quality of evidence and strength of rec-
ommendations. BMJ 2008;336(7650):924–926.
14. GRADE. Canadian Task Force on Preventive Health Care web-
site. http://canadiantaskforce.ca/methods/grade/. Accessed De-
cember 31, 2013.
This content downloaded from 130.92.9.56 on Wed, 23 Apr 2014 05:48:28 AM
All use subject to JSTOR Terms and Conditions
